BTC $64,143.92 -0.82%
ETH $1,804.33 -0.27%
BNB $584.20 -1.05%
XRP $0.9435 -1.57%
SOL $70.13 -1.59%
TRX $0.3045 -0.54%
DOGE $0.0582 -0.43%
ADA $0.1512 -1.36%
BCH $204.60 -1.66%
LINK $9.02 -1.93%
HYPE $66.29 -1.44%
AAVE $107.93 +1.37%
SUI $0.7097 -1.44%
XLM $0.1361 -1.91%
ZEC $852.33 -4.44%
AAPL $354.72 -0.47%
AMZN $260.87 -0.88%
GOOGL $288.01 -1.30%
MSFT $521.29 +0.31%
META $625.48 -1.19%
NVDA $158.58 -1.00%
TSLA $379.39 -1.95%
SNDK $808.16 -5.28%
INTC $55.60 -3.51%
SPCX $136.79 -1.21%
MU $725.06 -4.24%
AMD $506.31 -2.52%
BTC $64,143.92 -0.82%
ETH $1,804.33 -0.27%
BNB $584.20 -1.05%
XRP $0.9435 -1.57%
SOL $70.13 -1.59%
TRX $0.3045 -0.54%
DOGE $0.0582 -0.43%
ADA $0.1512 -1.36%
BCH $204.60 -1.66%
LINK $9.02 -1.93%
HYPE $66.29 -1.44%
AAVE $107.93 +1.37%
SUI $0.7097 -1.44%
XLM $0.1361 -1.91%
ZEC $852.33 -4.44%
AAPL $354.72 -0.47%
AMZN $260.87 -0.88%
GOOGL $288.01 -1.30%
MSFT $521.29 +0.31%
META $625.48 -1.19%
NVDA $158.58 -1.00%
TSLA $379.39 -1.95%
SNDK $808.16 -5.28%
INTC $55.60 -3.51%
SPCX $136.79 -1.21%
MU $725.06 -4.24%
AMD $506.31 -2.52%

Iambic completed an IPO financing of 150 million USD

2026-10-15 07:33:46

Iambic Therapeutics, in which NVIDIA has a stake, completed its initial public offering in the United States, raising $150 million, with an issue price of $16 per share, issuing approximately 9.38 million shares.

The company's market capitalization reached $758 million, and the funds raised will be used to advance three early-stage cancer drugs.

ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click , and we will handle it promptly.

app_icon
ChainCatcher Building the Web3 world with innovations.